Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.
The treatment of renal limited systemic vasculitis usually involves a combination of cytotoxic drugs and steroids. As shown by randomised prospective controlled trial, plasmapheresis may be of additional benefit for the management of patients with renal involvement severe enough to require dialysis...
主要な著者: | Elliott, J, Lockwood, C, Hale, G, Waldmann, H |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1998
|
類似資料
-
Monoclonal-antibody therapy in systemic vasculitis.
著者:: Mathieson, P, 等
出版事項: (1990) -
MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
著者:: Mathieson, P, 等
出版事項: (1990) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
著者:: Lockwood, C, 等
出版事項: (1993) -
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
著者:: Lockwood, C, 等
出版事項: (1993) -
MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
著者:: Isaacs, J, 等
出版事項: (1993)